Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
1,142,056
-
Shares change
-
-136,344
-
Total reported value, excl. options
-
$4,063,000
-
Value change
-
-$489,528
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$3.56
Significant Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q2 2020
26 filings reported holding CLPT - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value as of Q2 2020.
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,142,056 shares
of 28,234,434 outstanding shares and own 4% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (455,038 shares), PARSONS CAPITAL MANAGEMENT INC/RI (151,584 shares), Worth Venture Partners, LLC (76,361 shares), RENAISSANCE TECHNOLOGIES LLC (50,600 shares), BlackRock Inc. (49,872 shares), Merriman Wealth Management, LLC (47,690 shares), Mayo Clinic (47,148 shares), MILLENNIUM MANAGEMENT LLC (43,067 shares), KIRR MARBACH & CO LLC /IN/ (42,200 shares), and BROWN ADVISORY INC (28,000 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.